Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Postprocedural data</td><td class="align_center">Total population <i>n</i> = 94</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">ASA on discharge, <i>n</i> (%)</td><td class="align_center">93 (98.9)</td></tr><tr><td class="align_left">Clopidogrel on discharge, <i>n</i> (%)</td><td class="align_center">77 (81.9)</td></tr><tr><td class="align_left">Ticagrelor on discharge, <i>n</i> (%)</td><td class="align_center">16 (17)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Interventional Cardiology

tab4

Table 4

Table 4: Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study 